138 related articles for article (PubMed ID: 15670026)
1. Predictive value of plasma plasminogen activator inhibitor-1 for coronary restenosis: dependence on stent implantation and antithrombotic medication.
Christ G; Nikfardjam M; Huber-Beckmann R; Gottsauner-Wolf M; Glogar D; Binder BR; Wojta J; Huber K
J Thromb Haemost; 2005 Feb; 3(2):233-9. PubMed ID: 15670026
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor-1 predicts coronary in-stent restenosis of drug-eluting stents.
Katsaros KM; Speidl WS; Kastl SP; Zorn G; Huber K; Maurer G; Glogar D; Wojta J; Christ G
J Thromb Haemost; 2008 Mar; 6(3):508-13. PubMed ID: 18182031
[TBL] [Abstract][Full Text] [Related]
3. Postprocedural PAI-1 activity is a risk marker of subsequent clinical restenosis in patients both with and without stent implantation after elective balloon PTCA.
Prisco D; Fedi S; Antonucci E; Capanni M; Chiarugi L; Chioccioli M; Falai M; Giglioli C; Abbate R; Gensini GF
Thromb Res; 2001 Nov; 104(3):181-6. PubMed ID: 11672760
[TBL] [Abstract][Full Text] [Related]
4. Clopidogrel pretreatment abolishes increase of PAI-1 after coronary stent implantation.
Katsaros KM; Kastl SP; Huber K; Zorn G; Maurer G; Glogar D; Wojta J; Christ G; Speidl WS
Thromb Res; 2008; 123(1):79-84. PubMed ID: 18558425
[TBL] [Abstract][Full Text] [Related]
5. Impaired fibrinolysis early after percutaneous transluminal coronary angioplasty is associated with restenosis.
Sakata K; Miura F; Sugino H; Shinobe M; Shirotani M; Yoshida H; Mori N; Hoshino T; Takada A
Am Heart J; 1996 Jan; 131(1):1-6. PubMed ID: 8553994
[TBL] [Abstract][Full Text] [Related]
6. Thrombin-activatable fibrinolysis inhibitor (TAFI): a novel predictor of angiographic coronary restenosis.
Lau HK; Segev A; Hegele RA; Sparkes JD; Teitel JM; Chisholm RJ; Strauss BH
Thromb Haemost; 2003 Dec; 90(6):1187-91. PubMed ID: 14652655
[TBL] [Abstract][Full Text] [Related]
7. Effect of cilostazol on restenosis after coronary angioplasty and stenting in comparison to conventional coronary artery stenting with ticlopidine.
Tanabe Y; Ito E; Nakagawa I; Suzuki K
Int J Cardiol; 2001 May; 78(3):285-91. PubMed ID: 11376832
[TBL] [Abstract][Full Text] [Related]
8. Time course of prothrombotic and proinflammatory substance release after intracoronary stent implantation.
Wexberg P; Jordanova N; Strehblow C; Syeda B; Meyer B; Charvat S; Zorn G; Scheinig D; Wojta J; Huber K; Glogar D; Gyöngyösi M
Thromb Haemost; 2008 Apr; 99(4):739-48. PubMed ID: 18392332
[TBL] [Abstract][Full Text] [Related]
9. Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis.
Strauss BH; Lau HK; Bowman KA; Sparkes J; Chisholm RJ; Garvey MB; Fenkell LL; Natarajan MK; Singh I; Teitel JM
Circulation; 1999 Oct; 100(15):1616-22. PubMed ID: 10517732
[TBL] [Abstract][Full Text] [Related]
10. Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting.
Maresta A; Balducelli M; Latini R; Bernardi G; Moccetti T; Sosa C; Barlera S; Varani E; Ribeiro da Silva EE; Monici Preti A; Maggioni AP;
Catheter Cardiovasc Interv; 2005 Mar; 64(3):375-82. PubMed ID: 15736248
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of PAI-1 plasma activity and thallium perfusion imaging for restenosis after percutaneous transluminal angioplasty in clinically asymptomatic patients.
Gottsauner-Wolf M; Sochor H; Hornykewycz S; Beckmann R; Lang I; Probst P; Binder BR; Huber K
Thromb Haemost; 1999 Apr; 81(4):522-6. PubMed ID: 10235432
[TBL] [Abstract][Full Text] [Related]
12. Influence of residual stenosis after percutaneous coronary intervention with stent implantation on development of restenosis and stent thrombosis.
Sick P; Hüttl T; Niebauer J; Thiele H; Lauer B; Hambrecht R; Hentschel B; Schuler G
Am J Cardiol; 2003 Jan; 91(2):148-53. PubMed ID: 12521625
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of C-reactive protein after coronary stent implantation.
Gottsauner-Wolf M; Zasmeta G; Hornykewycz S; Nikfardjam M; Stepan E; Wexberg P; Zorn G; Glogar D; Probst P; Maurer G; Huber K
Eur Heart J; 2000 Jul; 21(14):1152-8. PubMed ID: 10924298
[TBL] [Abstract][Full Text] [Related]
14. Looking for the culprit of coronary in-stent restenosis: debatable role for the fibrinolytic system?
Viles-Gonzalez JF; Fuster V
J Thromb Haemost; 2005 Feb; 3(2):230-2. PubMed ID: 15670025
[No Abstract] [Full Text] [Related]
15. Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Popma JJ; Berger P; Ohman EM; Harrington RA; Grines C; Weitz JI
Chest; 2004 Sep; 126(3 Suppl):576S-599S. PubMed ID: 15383485
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor-1 and restenosis.
Garg N; Fay WP
Curr Drug Targets; 2007 Sep; 8(9):1003-6. PubMed ID: 17896951
[TBL] [Abstract][Full Text] [Related]
17. Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting.
Manzano-Fernández S; Pastor FJ; Marín F; Cambronero F; Caro C; Pascual-Figal DA; Garrido IP; Pinar E; Valdés M; Lip GYH
Chest; 2008 Sep; 134(3):559-567. PubMed ID: 18641090
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
[TBL] [Abstract][Full Text] [Related]
19. Early changes in local hemostasis activation following percutaneous coronary intervention in stable angina patients: a comparison between drug-eluting and bare metal stents.
Mahemuti A; Meneveau N; Seronde MF; Schiele F; Descotes-Genon V; Ecarnot F; Blonde MC; Mercier M; Racadot E; Bassand JP
J Thromb Thrombolysis; 2009 Oct; 28(3):333-41. PubMed ID: 18766300
[TBL] [Abstract][Full Text] [Related]
20. Impaired fibrinolysis determines the outcome of percutaneus transluminal coronary angioplasty (PTCA).
Fornitz GG; Nielsen P; Amtorp O; Kassis E; Abildgård U; Sloth C; Winther K; Ørskov H; Dalsgård J; Husted S
Eur J Clin Invest; 2001 Jul; 31(7):586-92. PubMed ID: 11454013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
